QA: Omeros CORP in us_pharma/2023

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001285819_2024_Omeros_CORP.pdf

Logs

Graph

Absolute values for 0001285819, Omeros CORP

  xvar xval
0 AssetsCurrent 217,898,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 1,950,000
3 remainder_Assets 158,421,000
4 LiabilitiesCurrent 53,316,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 49,097,637
9 ResearchAndDevelopmentExpense 116,593,324
10 remainder_Expenses 27,753,395
11 remainder_Revenues 14,321,169
12 remainder_NetIncome 92,821,368
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 378,269,000
1 Liabilities 53,316,000
2 Expenses 193,444,356
3 Revenues 14,321,169
4 StockholdersEquity 324,953,000
5 NetIncome -86,301,819
6 ComprehensiveNetIncome -86,301,819
7 BaseVar 366,085,946
8 EconomicCapitalRatiobeforeLimitedLiability 2.88
9 EconomicCapitalRatio 3.61

Edgar->Model Mapping

Feature Distribution

Change over Time